The design of compartmentalized carriers for advanced drug delivery systems or artificial cells and organelles is of interest for biomedical applications. Herein, we present a polymer carrier microreactor that contains two different classes of subcompartments: multilayered polymer capsules and liposomes. We encapsulate 50 nm-diameter liposomes and 300 nm-diameter polymer capsules into a larger polymer carrier capsule, demonstrating control over the spatial positioning of the subcompartments, which are either "membrane-associated" or "free-floating" in the aqueous interior. Selective and spatially dependent degradation of the 300 nm-diameter subcompartments (without destroying the structural integrity of the enzyme-loaded liposomes) is also shown by performing an encapsulated enzymatic reaction using the liposomal subcompartments. These findings cover several important aspects toward the development of engineered compartmentalized carrier vessels for the creation of artificial cell mimics or advanced therapeutic delivery systems.
Introduction
Biomimicry, or the creation of artificial mimics, holds great potential since synthetic biological systems will allow for a better understanding of biology by dissociating parameters that are closely correlated in nature. [1] Since cells are the integral components of biological systems, the creation of artificial cells remains the focus of biomimicry and, thus, the past years have seen a steady stream of reports of model systems aimed at the creation of artificial cell mimics. [1a, 2] Two completely different approaches have arisen for the creation of artificial cells: i) systems that encapsulate cell components, i.e., using cells as building blocks (top-down approach) [3] and ii) synthetic microreactors that combine minimal components to create simple, typically one, cell function (bottom-up approach). [2] [3] [4] Although the synthetic microreactors created from a bottom-up approach are still extremely simplified versions of cell architectures, the advantages of creating such biomimetic nanocontainers are two-fold: from the fundamental point of view, the creation of deliberately simplified systems is a powerful strategy to unravel the complexity of living cells while, at the same time, those biomimetic containers are an efficient tool with applications in the field of drug delivery, encapsulated catalysis, and diagnostics. [5] However, the first step to mimic the structure of a cell is already very challenging: dividing the space in a controllable manner into subunits is a feature of eukaryotic cells, which, given their spatially confined environments (i.e., organelles), are able to separate in time and space the functional processes needed for its survival. Thus, for the successful creation of cell mimics, compartmentalization is essential.
However, despite the need of a broad range of synthetic microreactors created from a bottom-up approach, few examples of successful subcompartmentalized carriers have been reported to date.
Those architectures are typically made of a single component and include vesosomes (liposomes within a carrier liposome), [6] two compartment micellar assemblies, [7] polymer caspsule(s) within a polymer capsule, [8] and polymersomes within a polymersome. [1b, 9] Dual-composition systems in which the carrier container and the subcompartments are of different nature are even more scarce and include polymer hydrogel capsules containing cubosomes [10] or polymersomes, [11] cellosomes (yeast cells associated with a polymer membrane), [12] CaCO3 particles with subcompartments composed of biomolecules, [13] and our recently introduced capsosomes, [14] which comprise thousands of intact liposomes embedded into a polymer carrier capsule and are, to date, the most thoroughly studied subcompartmentalized system. [5] Capsosomes, as dual-composition systems, exploit the advantages of the different nature of the carrier vessel and the subcompartments. While the polymer carrier capsule provides the structural scaffold with controllable permeability, the liposomes, which partition the capsule's interior into subcompartments, are well suited to encapsulate small and/or fragile cargo due to their impermeable nature. We have broadly characterized the fabrication of capsosomes [15] and have developed a unique approach to non-covalently anchor liposomes to polymer layers using cholesterol. [14, 16] We have also shown control over the position of the liposomal subcompartments; that is, capsosomes containing "membrane-associated" or "free-floating" (filling the cavity of the capsules) subcompartments. [17] Further, we have demonstrated the functionality of capsosomes by performing two different triggered enzymatic assays [14, 17] and a two-step enzymatic catalytic reaction. [18] The absence of inherent cytotoxicity of capsosomes (by performing a cell viability assay) [19] makes capsosomes promising candidates for biomedical applications.
We have also reported 3 µm-diameter polymer hydrogel capsules containing 300 nm-diameter subcompartments, namely subcompartmentalized hydrogel capsules, in which both the carrier capsule and the subcompartments are semipermeable, and we demonstrated the selective degradation of the subcompartments and the carrier capsules to different chemical stimuli. [8c] In addition, we pioneered continuous reactions performed in semipermeable polymer hydrogel capsules that mimic some of the activities performed in different cell organelles, such as the enzymatic degradation of DNA [20] or RNA synthesis. [21] However, all carriers containing subcompartments reported to date, including capsosomes and subcompartmentalized hydrogel capsules, have a common feature: all of the subcompartments are of the same type. On one hand, for the design of successful mimics of cells, several types of compartments should be encapsulated since, in biological cells, compartmentalization is not limited to lipid containers; other small scale containers such as chaperones, which exert functions such as assisting in protein folding, ferritins, involved in iron metabolism, or proteasomes for protein degradation, which are not formed by a lipid bilayer, are also cell compartments. [22] On the other hand, when making use of advanced compartmentalized carriers for biomedical applications such as drug delivery, given the tremendous complexities of pharmacokinetics and pharmacodynamics of potential drugs and the immense variety of human diseases, it is envisioned that carriers containing different types of subcompartments will be an optimal form of drug delivery. Using multiple and different compartments in which their chemistry and physics can be modified in different ways due to their intrinsic different properties, will offer a new broad range of multiple and diverse possibilities that are not possible when using a single type of subcompartment.
In this work, we give a first insight into the creation of a synthetic microreactor containing two different types of subcompartments: liposomes and polymer hydrogel capsules, and demonstrate the specific functionality of the different subunits. We envision that by incorporating two different types of subcompartments into a polymer carrier vessel, complementary cell functions could potentially be performed in parallel within the same container, bringing us a step closer to the creation of advanced cell mimics that are able to perform several cell functions at the same time.
While liposomes will equip the synthetic microreactor with all the features already described and reported for capsosomes, the polymeric subcompartments will endow them with the additional functionalities of a semipermeable capsule, since liposomes have some limitations such as a low loading capacity or a lack of permeability toward small molecules. As an example, the incorporation of polymeric subcompartments containing a semipermeable membrane could allow the synthetic microreactor to perform continuous reactions in which the intake of reagents and release of products is constant, while liposomes will perform a different task, by initiating the enzymatic reaction in response to a trigger.
In this study, which is aimed at the creation of an advanced synthetic microreactor, we: i) encapsulate 300 nm-diameter polymeric hydrogel capsules (HC300) and liposomes separated by different polymer layers within a (bio)degradable polymer membrane (Scheme 1); ii) study the kinetics of the liposomal adsorption onto HC300-coated silica templates; iii) make use of the properties of poly(N-vinyl pyrrolidone-block-(cholesteryl acrylate)) (PVPc) as a polymer separation layer to assemble a carrier vehicle containing "free-floating" liposomal subcompartments and "membrane-associated" HC300; iv) demonstrate the selective degradation of the polymeric subcompartments under reductive conditions (in contrast to the liposomal subcompartments, which remain intact); v) show that the degradability of the HC300 depends on the spatial positioning of the liposomes; and vi) confirm the functionality of these compartmentalized carriers through an encapsulated enzymatic reaction.
Results and Discussion

Microreactor Assembly
The assembly of both HC300 and the carrier vessels is based on the layer-by-layer (LbL) technique by the consecutive alternate adsorption of poly(N-vinyl pyrrolidone) (PVP) and thiolated poly(methacrylic acid) (PMASH) onto sacrificial particle templates. The PMASH thiol groups in the multilayers were cross-linked and upon core removal the capsules were washed in HEPES buffer (10 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 150 mM NaCl, pH 7.4) to yield negatively charged, single-component PMA capsules (Figure 1a ) [8c, 23] .
We assembled a heterogeneous microreactor by first adsorbing HC300 onto amine-modified, positively charged, 3 µm-diameter silica template (SiO2 + ) particles via electrostatic interactions. [8c] Next, two different polymer separation layers (poly(L-lysine) (PLL) and/or poly(methacrylic acid)co-(cholesteryl methacrylate) (PMAc)) in HEPES buffer were deposited prior to adsorption of different types of nitrobenzoxadiazole (NBD)-labeled liposomes (i.e., zwitterionic unsaturated liposomes (L u,zw NBD); negatively charged unsaturated liposomes (L u,-NBD); zwitterionic saturated liposomes (L s,zw NBD); negatively charged saturated liposomes (L s,-NBD)) to identify which polymer or combination of polymers allows the maximum adsorption of each type of liposomes onto the HC300-coated SiO2 + particles (SiO2 + -HC300). We chose PLL and the combination PLL/PMAc since both polymers have been previously demonstrated to be effective precursor layers for liposome anchoring. [14, 15b, 16, 18-19, 24] The SiO2 + -HC300 core-shell particle/polymer separation layer/liposome assembly was then capped with PMAc in HEPES buffer and the polymer carrier capsule was created by the sequential deposition of five bilayers of PVP and PMASH in NaOAc buffer (20 mM NaOAc (sodium acetate), pH 4.0). [23] The thiols in the polymer multilayer film of the core-shell particles were then cross-linked followed by dissolution of the silica particle templates in 5 M hydrofluoric acid (HF). The fluorescence intensity of the core-shell particles due to the fluorescent liposomes was monitored by flow cytometry. The fluorescence reading measured after adsorption of the liposomes was set at 100% and compared to the fluorescence intensity of the core-shell particles after cross-linking and after core dissolution at both assembly (NaOAc buffer) and physiological (HEPES buffer) conditions. Figure 1b shows the measured decrease in fluorescence intensity for eight different combinations of polymer separation layers and liposomes.
The separation layer adsorbed between the HC300 and the unsaturated liposomes has a significant influence on the retention of both zwitterionic (L u,zw NBD) and negatively charged (L u,-NBD) liposomes. For L u,zw NBD the combination of PLL/PMAc as separation layer led to a reduction of ~35% in fluorescence intensity in contrast to a decrease of only ~6% when PLL was used as separation layer, when comparing the decrease in fluorescence intensity after the initial liposome deposition step (Figure 1bi , dark gray bars) and after the assembly of the core-shell particles (Figure 1bi , light gray bars). This finding can be explained by the fact that when employing the combination of PLL/PMAc as separation layer, the L u,zw NBD are sandwiched between two layers of PMAc assembled in HEPES buffer, thus being negatively charged and repelling each other. The electrostatic repulsion between the capping and separation polymer layers will prevent efficient embedding of the cholesterol moieties into the liposomes, thus promoting the displacement of the liposomes. In contrast, when PLL is employed as separation layer, the L u,zw NBD are sandwiched between a positively charged PLL separation layer and a negatively charged PMAc capping layer, making the electrostatic interactions favorable and, in turn, promoting stable anchoring of the liposomes due to the cholesterol moieties of the capping layer. However, as shown in Figure 1bii , the liposomal trapping efficiency appears to be dependent on the separation layer in an opposite manner when encapsulating L u,-NBD. When using the combination of PLL/PMAc to separate L u,-NBD from the HC300, a fluorescence decrease of only ~20% was observed (Figure 1bii , light gray bars) compared to a decrease of ~40% in fluorescence when PLL was used as a separation layer (Figure   1bii , light gray bars). A possible explanation for these observations is that when employing PLL as a separation layer (in this case the liposomes are negatively charged), upon the addition of the negatively charged PMAc capping layer, a strong electrostatic repulsion between the PMAc capping layer and the negatively charged liposomes will occur, and given that the liposomes are bound to PLL by electrostatic interactions, the PMAc capping layer may strongly interact with the underlying PLL and displace loosely bound liposomes. However, when the combination of PLL/PMAc is used as a separation layer, stable anchoring of the negatively charged liposomes will be provided by the cholesterol moieties of the PMAc, and, upon addition of PMAc capping layer, less liposomal displacement or loss will take place.
For both L u,zw NBD and L u,-NBD, decreases in fluorescence intensity of the microreactors were observed after core removal with HF (~20% when encapsulating L u,zw NBD and ~5% for L u,-NBD, independent of the separation layer employed (Figure 1b , i and ii, respectively, white bars)). This finding is consistent with our previous report. [17] Reductions in the fluorescence intensity were also observed when switching the microreactors from NaOAc buffer (Figure 1b , i and ii, white bars) to HEPES buffer (Figure 1b , i and ii, bars with stripes), a result that can be explained by the low pHdependent fluorescence intensity of the NBD fluorophore [25] and/or by PVP release, which could detach the liposomes, or temporarily increase the permeability of the membrane, thus facilitating the liposomal loss. However, at this stage it is unclear why there are large differences in the decrease in fluorescence as a function of liposome/separation layers employed.
In contrast to the results observed for unsaturated liposomes, when encapsulating both zwitterionic and negatively charged saturated liposomes (L s,zw NBD and L s,-NBD) the decrease in fluorescence intensity after the core-shell particle assembly was similar for all four assemblies (Figure 1b, iii and iv, light gray bars), suggesting that the adsorption of saturated liposomes onto the coated silica particles was independent of the separation layer. This effect could be attributed to the ordered gel phase state of the liposomes at room temperature, which promotes more efficient anchoring of the cholesterol moieties. These findings suggest that, when saturated liposomes are employed, the cholesterol-driven anchoring between the PMAc capping layer and the liposomes is superior over the electrostatic interactions between PMAc and the separation layers.
The stronger binding between cholesterol and saturated liposomes can also be noted by the small drop in fluorescence intensity after core removal in NaOAc buffer (Figure 1b, iii and iv, white bars) and when switching to HEPES buffer (Figure 1b, iii and iv, bars with stripes), suggesting that the stronger cholesterol binding with the saturated liposomes prevents them from being detached upon PVP release.
Kinetics of Liposomal Adsorption
Of the eight previously studied combinations, we chose the optimal separation layer(s) for each following the same pattern. Thus, since similar adsorption curves were obtained for three of the four separation layer/liposome combinations, we conclude that the adsorption rate of the liposomes is largely independent of the type of the polymer separation layer and the liposomal composition, except when L u,-NBD are employed using PLL as a separation layer.
Structural Characterization
The heterogeneous carrier vehicles containing liposomes and polymer capsules as Controlling the spatial positioning of the subcompartments is expected to be an advantage for the functional performance of the microreactors. The presented assembly has both types of subunits "membrane-associated", i.e., attached to the polymer membrane of the carrier capsules. In a first step, to gain control over the position of the subcompartments in the heterogeneous vessel, we inverted the assembly order of the liposomes and the HC300. Briefly, we assembled the microreactor by coating SiO2 + particles with PMAc, followed by the adsorption of L s,zw NBD, and then depositing PMAc and PLL as polymer separation layers. The HC300(AF633) were adsorbed (see Materials and
Methods section for details), followed by the sequential deposition of 5 bilayers of PMASH and PVP prior to cross-linking and silica core removal. Non-agreggated microreactors containing L s,zw NBD as the inner subcompartment layer and HC300(AF633) as the outer layer were obtained, as depicted in Figure 3b , which shows the merged CLSM image of L s,zw NBD (green) and HC300(AF633) (red), giving a yellow color. In a similar manner as when the liposomes were assembled in the microreactor as the outer subcompartment layer and the HC300(AF633) as the inner subcompartment layer (Figure   3ai ), when inverting the order of the subcompartments, the L s,zw NBD were also homogeneously distributed along the carrier vessel, as shown by the uniformly distributed green or yellow fluorescence (Figure 3b ) while the HC300(AF633) were not evenly embedded within the 3 µmdiameter polymeric container, as shown by the intermittent yellow fluorescence arising from the carrier vessels (Figure 3b ).
Microreactors with "Free-Floating" Liposomal Subcompartments
We have previously reported the assembly of capsosomes containing "free-floating" liposomal subcompartments within the interior of the capsules, which was inspired by the arrangement of organelles inside eukaryotic cells. [17] With the goal to obtain a heterogeneous microreactor with control over the spatial positioning of the subunits, i.e., containing the liposomal subcompartments "free-floating" in the vessel's interior, we made use of the properties of PVPc. This block copolymer consists of a short block of cholesteryl acrylate to bind liposomes and a longer PVP segment, [17] which is uncharged and allows hydrogen bonding to other polymer layers. The diblock architecture minimizes physical entanglement of the polymer with the membrane of the carrier capsule promoting the localization of the liposomal compartments into the hollow interior. [17] The assembly was performed by sandwiching L s,zw NBD between two layers of PVPc, followed by the deposition of a PMA layer. Three different approaches to attach HC300(AF633) subcompartments were employed (see Materials and Methods for details). The first approach relies on the thioldisulfide exchange. [26] The SiO2/PVPc/L s,zw NBD/PVPc core-shell particles were first incubated with PMA, subsequently with PVP and then by the adsorption of PMA-pyridine dithioethylamine (PD), followed by the adsorption of the HC300(AF633) in NaOAc buffer. The second method takes advantage of electrostatic interactions to deposit the HC300(AF633) subunits onto SiO2/PVPc/L s,zw NBD/PVPc/PMA/PLL core-shell particles in MES buffer, while the third procedure relies on hydrogen bonding to bind the HC300(AF633) subcompartments onto the SiO2/PVPc/L s,zw NBD/PVPc/PMA core-shell particles. The coated particles were incubated in a PVP solution and protonated HC300(AF633) were allowed to adsorb overnight. For each of the three methods, the PVP/PMASH membrane was assembled as described previously. After cross-linking of the thiol groups and core removal, stable microreactors were obtained. Figure 4 shows fluorescence microscopy images of the microreactors assembled by the three different methods in NaOAc and HEPES buffer. As depicted in Figure 4ai and Figure 4bi , when making use of PMA-PD or PLL to bind the HC300(AF633), at NaOAc buffer assembly conditions , the liposomes were homogeneously distributed along the carrier vessel while the polymeric subcompartments appear disseminated heterogeneously along the 3 µm-diameter container. This finding is similar to that previously described for the microreactors containing PLL/PMAc as separation layers and HC300(AF633) and L s,zw NBD as inner and outer subcompartment layers, respectively (Figure 3ai) or vice versa (Figure   3b ). However, when employing hydrogen bonding to attach the HC300(AF633), although the liposomes appear evenly distributed along the carrier vessel, the hydrogen bond interaction to attach the polymeric subcompartments appears to be ineffective, since the yellow fluorescence arising from the merged fluorescence images of HC300(AF633) (red) and L s,zw NBD (green) is irregular and only covers a small part of the carrier vessel.
Following resuspension of the capsules in HEPES buffer, the liposomes were detached from the carrier membrane, as shown by the green fluorescence signal homogeneously distributed within the interior of the carrier vessel while the HC300(AF633) subunits remained associated with the carrier wall (Figure 4aii, Figure 4bii, and Figure 4cii , for the three different methods, respectively).
Enzymatic Reactions
To confirm the incorporation of intact liposomes inside the carrier vehicles, we conducted a colorimetric enzymatic reaction by encapsulating the enzyme -lactamase in an assembly consisting of SiO2 + /HC300/PMA/PLL/PMAc/L s,zw -lac/PMAc/PVP/(PMASH/PVP)5. The PVP/PMASH membrane was assembled as described previously but, to prevent enzyme oxidation and thus loss of functionality, the cross-linking of the thiol groups was carried out using thiol-maleimide chemistry by incubating the particles with an excess of the homobifunctional non-degradable linker 1,8-Bismaleimidodiethyleneglycol (BM(PEG)2) and core removal was performed by using buffered HF (2 M HF/8 M ammonium fluoride (NH4F)). We previously employed this enzymatic assay, where -lactamase converts the yellow substrate nitrocefin into its red hydrolyzed product, demonstrating the functionality of capsosomes. [14, 15b] As depicted in Figure 5 , 
Degradation of HC300 and Preservation of Liposome Functionality
With the goal of demonstrating the feasibility of addressing the two types of subunits individually, we attempted to degrade the polymeric subcompartments using a chemical trigger, followed by examining the performance of an enzymatic reaction employing the liposomal subunits. We have previously demonstrated that HC300 cross-linked via oxidation (employing chloramine T), entrapped within a larger non-degradable PMA carrier vessel can be selectively degraded.
[8c] Herein, we sought to demonstrate that the selective degradation of the HC300 subcompartments does not affect the coencapsulated liposomes. To this end, we employed assemblies with different spatial positions of the two types of subunits, i.e., liposomes as the inner subcompartment layer and HC300 as the outer subcompartment layer and vice versa, and exposed them to simulated physiological concentrations (5 mM) of reduced glutathione (GSH). For this assembly, the HC300 were cross-linked with chloramine T to obtain degradable disulfide bonds, while the 3 µm-diameter carrier capsule was cross-linked by making use of the homobifunctional linker BM(PEG)2 to give rise to non-degradable carrier capsules. Interestingly, when assembling a microreactor containing the liposomes as the outer subcompartment layer, the Alexa Fluor 488 (AF488)-labeled HC300 (HC300(AF488)) were not degraded at simulated physiological concentrations of GSH, as shown by the DIC and fluorescence microscopy images before (Figure 6ai and Figure   6aiii , respectively) and after (Figure 6aii and Figure 6aiv , respectively) incubation with GSH. The images are identical, suggesting that liposomes situated on the outer liposome layer provide an impermeable barrier, thus preventing access of the GSH peptide into the inner HC300 layer. In contrast, when the liposomes are in the inner subcompartment layer, the HC300(AF488) were completely degraded after 24 h of incubation with GSH, as shown by the smooth outline of the carrier vessels (Figure 6bii ) and the disappearance of the fluorescence signal arising from the labeled HC300 (Figure 6biv) .
Further, we also found that the presence of GSH only affects the polymeric subcompartments whereas the liposomes remained intact, as shown by the triggered β-lactamase assay after 24 h of incubation with GSH and nitrocefin. As shown in Figure 6c , only when β-lactamase-loaded liposomes were lysed using the surfactant TX, the yellow substrate nitrocefin (Figure 6ci and   Figure 6ciii ) was converted into its red hydrolyzed product (Figure 6cii and Figure 6civ ). This demonstrates the possibility to selectively address the subunits.
Conclusions
We have reported the assembly of a micrometer-sized vessel containing subcompartments of two different compositions (liposomes and polymer capsules), and have demonstrated control over the spatial positioning of the subunits. This heterogeneous assembly was employed to conduct a triggered enzymatic reaction, and the possibility to selectively address the polymeric and lipid subcompartments was shown. These results demonstrate the potential of these heterogeneous compartmentalized carriers in biomedical applications as highly sophisticated microreactors for triggered encapsulated reactions or as drug delivery vehicles.
Experimental Section
Materials Polymer Synthesis: Thiol-modified poly(methacrylic acid) (PMASH, 15 kDa), [26] which in this study consists of a PMA backbone with 14% pendant thiol moieties, poly-(methacrylic acid)-co-(cholesteryl methacrylate) (PMAc, 12.4 kDa), [16] and poly(N-vinyl pyrrolidone)-block-(cholesteryl acrylate) (PVPc, 10.9 kDa) [17] were synthesized according to previously published protocols.
Assembly of 300 nm-diameter PMA Capsules (HC300): The preparation and the labeling of the HC300 is described elsewhere. [8c] Microreactor Assembly: Microreactors were assembled via the layer-by-layer (LbL) technique. The silica cores were dissolved using a 5 M HF solution for 2 min (Caution: hydrofluoric acid is extremely corrosive and should be handled with care), followed by several washing cycles in NaOAc buffer (4500 g, 3 min). When the microreactor was assembled with β-lactamase-loaded liposomes the core was removed using a 2:1 v/v 2 M HF/8 M NH4F solution for 2 min, followed by several washing cycles in NaOAc buffer (4500 g, 3 min).
The microreactors were post-labeled with a fluorescent dye when required by incubation in a solution of AF488 or AF633 (5 × 10 -3 mg mL -1 in MES buffer (50 mM, pH 6.0, 1 h)). The microreactors were then washed three times in HEPES buffer (1060 g, 30 s).
(b) Microreactors containing liposomes as the inner subcompartment layer and HC300 as the outer subcompartment layer. 3 µm-diameter SiO2 + particles (5 wt%) were washed three times in HEPES buffer (1060 g, 30 s). The particles were then suspended in a PMAc solution (1 mg mL -1 , 15 min), washed three times in HEPES, followed by the adsorption of the liposomes (1.25 mg mL -1 , 40 min), washed three times in HEPES, and subsequently the PMAc capping layer was adsorbed (1 mg mL -1 , 15 min), washed three times in HEPES and incubated with a PLL solution (1 mg mL -1 , 10 min), washed three times in HEPES, followed by the adsorption of HC300 in HEPES buffer for 5 min with constant shaking. PMA was added to a final concentration of 1 mg mL -1 and incubated for 10 min with constant shaking. The sample was then washed twice in HEPES buffer and once in NaOAc buffer (1060 g, 30 s). The polymer membrane was assembled by the sequential deposition of five bilayers of PVP and PMASH (1 mg mL -1 , 10 min) in NaOAc (pH 4.0). The thiols within the polymer layers were cross-linked and the silica core was dissolved as described previously. The PVP was released from the microreactors by washing them into HEPES buffer.
Microreactors containing "free-floating" liposomal subcompartments and "membraneassociated" HC300. 3 µm-diameter SiO2 particles (5 wt%) were washed three times in NaOAc buffer (1060 g, 30 s), the particles were incubated in a PVPc solution (1 mg mL -1 , 15 min), washed three times in NaOAc, incubated in a liposomal solution (L s,zw NBD) at 37 °C (1.25 mg mL -1 , 40 min), washed three times in NaOAc, followed again by the adsorption of a PVPc solution (1 mg mL -1 , 15 min) and washing three times in NaOAc. After these steps, three different assembly methods were employed:
(a) The coated particles were incubated with a PMA solution (1 mg mL -1 , 10 min), washed three times in NaOAc buffer, suspended in a PVP solution (1 mg mL -1 , 10 min), and washed three times in NaOAc. Subsequently they were allowed to interact with a PMA-PD solution (1 mg mL -1 , overnight), washed three times in NaOAc, followed by the adsorption of HC300 in NaOAc buffer for 5 min with constant shaking. PMA was added to a final concentration of 1 mg mL -1 and incubated for 10 min with constant shaking. The sample was then washed three times in NaOAc and the polymer membrane was assembled as described previously followed by the thiol cross-linking and the core dissolution.
(b) The coated particles were incubated with a PMA solution (1 mg mL -1 , 10 min), washed three times in MES buffer (100 mM, pH 5.0), and then incubated with a PLL solution (1 mg mL -1 , 10 min), washed three times in MES buffer (100 mM, pH 5.0), and subsequently HC300 suspended in MES buffer (100 mM, pH 5.0) were added dropwise and incubated for 5 min with constant shaking, followed by the addition of PMA to a final concentration of 1 mg mL -1 . The coated particles were then washed once in MES (100 mM, pH 5.0) buffer and 2 times in NaOAc buffer. The assembly of the polymer membrane, the thiol cross-linking, and the core dissolution were then performed as described previously.
(c) The coated particles were incubated with a PMA solution (1 mg mL -1 , 10 min), washed three times in NaOAc buffer, and then incubated with PVP (1 mg mL -1 , 10 min) washed three times in NaOAc, and HC300 in NaOAc buffer were added dropwise and then incubated overnight with constant shaking. The subsequent assembly of the polymer membrane, thiol cross-linking, and core dissolution were then performed as described previously. thiolated poly(methacrylic acid) (PMASH) in NaOAc buffer. The thiols in the polymer multilayer film were then crosslinked followed by core dissolution. The microreactors were then washed in HEPES buffer. b) Liposome retention depending on the polymer separation layers deposited onto SiO2 + -HC300 core-shell particles. The fluorescence intensity of core-shell particles or hollow microreactors due to the presence of NBD-labeled liposomes (LNBD) at different stages of the assembly is shown: after the initial liposome deposition (dark gray), after the assembly of the coreshell particles (gray), hollow microreactors in NaOAc buffer (white), and in HEPES buffer (stripes), for liposomes with different lipid compositions: i) unsaturated zwitterionic (L u,zw NBD); ii) unsaturated negatively charged (L u,-NBD); iii) saturated zwitterionic (L s,zw NBD); and (iv) saturated negatively charged (L s,-NBD). The red arrows indicate the reduction in the fluorescence intensity of the adsorbed liposomes (or liposome loading efficiency) before dissolution of the microreactor core. 
